After successfully organising CMC and Quality Culture seminars in Melbourne, Sydney, Brisbane, Auckland, and Singapore, Aphex Pharma Solutions is hosting Australia’s first Pharmaceutical Development Conference (PDC) 2024 at Macquarie Park (Sydney) on 22nd of October.
PDC 2024 (Sydney) will be the first conference of its kind which will connect pharmaceutical scientists and professionals, product sponsors, solution providers, business development executives and students to discuss industry challenges related to formulations, manufacturing, analytical, preclinical, and clinical development.
For more Information, please contact us at pdc2024@aphexpharma.com
Register now and save A$300. Early bird discount finishes August 25th 2024.
Executive Director and Chief Scientific Officer at QBiotics Group
Chief Scientific Officer at Agilex Biolabs Pty Ltd
Principal Toxicologist at Agilex Biolabs Pty Ltd
Clinical Projects Manager at DataPharm Australia
BIOSTATISTICIAN | MBBS, BMEDSCI(HONS), GBIOSTAT, MBIOSTAT, PHD
Senior Director, Clinical Operations, APAC at Precision for Medicine
Global Head of Early Phase at George Clinical
Executive Chairman at Opyl Limited
Managing Director and Director Formulytica
Director Innovation and Biologics Deputy Managing Director Formulytica
Senior Vice President R&D at NovaCina
Product & Sales Manager at Anton Paar
Director at CBE Pty Ltd (Asia Pacific)
Chief Executive Officer at CBE Pure Solutions
Head of Quality and Regulatory Affairs at Qbiotics
Director of Quality and CMC regulatory, QBiotics | Managing Director Aphex Pharma Solutions
Quality Specialist at IQVIA
Laboratory Scientists
Regulatory Managers
Formulations Scientists
Clinical Trial Managers
MS&T Leaders
Quality Professionals
Project Managers
CMC Managers